Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-11-01
1989-10-31
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31485
Patent
active
048777919
ABSTRACT:
A method of treating patients suffering from interstitial cystitis comprises daily administration to such patients of from about 1 to about 50 mg of the narcotic antagonists nalmefene or naltrexone. The nalmefene or naltrexone may be administered in equally divided doses from one to four times daily, preferably by the oral route. Parenteral administration may be utilized where suitable.
REFERENCES:
Goldstein et al., Ann. Int. Med., 98:30-34 (1983).
Simmons et al., Am. Surg., 24:664-667 (1958).
Smith et al., Arch. Path., 93:76-81 (1972).
Parivar et al., Brit. J. Urol., 58:239-244 (1986).
Tomson et al., Lancet, Nov. 2, 1985, 1010-1011.
Parsons, Urology, 29 (supplement):14-16 (1987).
Feltis et al., J. Urol., 138: 42-43 (1987).
Casale et al., J. Aller, Clin. Immunol., 73:775-781 (1984).
Baker Cummins Pharmaceuticals, Inc.
Rose Shep K.
LandOfFree
Method of treatment for interestitial cystitis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treatment for interestitial cystitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment for interestitial cystitis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-626247